IRONWOOD PHARMACEUTICALS INC - NOTE 0.750% 6/1

Historical Portfolio Holders from Q3 2020 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Debt / NOTE 0.750% 6/1
Principal, excl. options Q2 2024
0
Holdings value Q2 2024
$0
Value change Q2 2024
-$208M
Grand Portfolio weight change Q2 2024
0%
Number of holders
0
Number of buys Q2 2024
0
Number of sells Q2 2024
-17
Average buys Q2 2024 %
0
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q2 $0 $0 -$208M 0
2024 Q1 $209M $208M +$2.95M $0.99 17
2023 Q4 $202M $214M -$60.9K $1.05 18
2023 Q3 $206M $204M +$4.42M $0.99 23
2023 Q2 $201M $203M +$1.62M $1.00 23
2023 Q1 $200M $201M +$25.5M $1.00 20
2022 Q4 $174M $188M -$6.55M $1.07 23
2022 Q3 $188M $189M -$11.8M $1.00 23
2022 Q2 $199M $210M -$19.5M $1.05 19
2022 Q1 $215M $243M +$18.6M $1.14 19
2021 Q4 $199M $221M -$588K $1.11 18
2021 Q3 $199M $235M -$184K $1.18 18
2021 Q2 $199M $234M -$9.49K $1.18 18
2021 Q1 $199M $221M -$39.6K $1.11 17
2020 Q4 $199M $223M -$586K $1.12 18
2020 Q3 $200M $198M +$198M $0.99 17